Table 1:

Baseline characteristics in control and dengue cohorts

VariableGroup; no. (%) of participants*p value*
Control
n = 13 787
With dengue
n = 13 787
Sex0.005
 Female6628 (48.1)6862 (49.8)
 Male7159 (51.9)6925 (50.2)
Age, yr, mean ± SD44.2 ± 14.344.6 ± 19.30.05
 ≤ 302336 (16.9)3581 (26.0)
 31–609528 (69.1)6886 (49.9)
 > 601923 (13.9)3320 (24.1)
Total admission days, mean ± SD10.8 ± 97.610.5 ± 51.50.7
Comorbidity
 Atrial fibrillation and flutter62 (0.4)64 (0.5)0.9
 Cancer330 (2.4)292 (2.1)0.1
 COPD390 (2.8)371 (2.7)0.5
 Chronic renal failure79 (0.6)86 (0.6)0.6
 Diabetes mellitus645 (4.7)625 (4.5)0.6
 Dyslipidemia347 (2.5)306 (2.2)0.1
 Heart failure139 (1.0)133 (1.0)0.7
 Hypertension898 (6.5)876 (6.4)0.6
 Ischemic heart disease440 (3.2)447 (3.2)0.8
Follow-up, yr, mean ± SD7.89 ± 3.717.58 ± 3.77NA
Top 5 reasons for admissionNA
 Digestive8865 (64.3)DF: 12 477 (90.5)
 Cardiopulmonary783 (5.7)DHF: 1310 (9.5)
 Metabolic533 (3.8)
 Trauma398 (2.9)
 Genitourinary226 (1.6)
  • Note: COPD = chronic obstructive pulmonary disease, DF = dengue fever, DHF = dengue hemorrhagic fever, NA = not applicable, SD = standard deviation.

  • * Student t test for continuous variables and χ2 test for categorical variables.

  • For patients in the dengue group, there were only 2 top reasons: dengue fever and dengue hemorrhagic fever.